Data / Form D filings / AGIOS PHARMACEUTICALS INC
AGIOS PHARMACEUTICALS INC: Form D filings
AGIOS PHARMACEUTICALS INC, a pharmaceuticals company in Cambridge, MA, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on November 22, 2011, reports $78 million sold of a $78 million offering to 19 investors.
Find out what AGIOS PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 38 Sidney Street, 2nd Floor, Cambridge, MA, 02139
- Phone
- (617) 272-5275
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1439222
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 22, 2011 | New notice | $78,000,001 | $78,000,001 | $0 | 19 | Nov 16, 2011 | sec.gov |
| Apr 26, 2010 | New notice | $8,823,937 | $8,823,937 | $0 | 1 | Apr 14, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John C. Maraganore | Director | |
| Marc C. Tessier-Lavigne | Director | |
| Kevin C. Starr | Director | |
| Duncan Higgons | Executive Officer | |
| Lewis C. Cantley | Director | |
| Doug Cole | Director | |
| David Schenkein | Executive Officer, Director | |
| Robert Nelsen | Director | |
| Perry C. Karsen | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Nov 21, 2011 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AGIOS PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.